A fast-growing aged population means rising unmet need for effective therapeutics to slow the progression of aging/ age-related diseases. Vincere’s compounds aim to slow or halt Parkinson’s disease & related indications by improving mitochondrial quality control, a mechanism that degrades with aging, using proprietary computational models to nominate molecular switches that maintain these processes & discover compounds that modulate these targets